Remed Co (XKRX:302550) FCF Margin % : 15.34% (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Remed Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Remed Co's Free Cash Flow for the three months ended in Mar. 2025 was ₩989 Mil. Remed Co's Revenue for the three months ended in Mar. 2025 was ₩6,443 Mil. Therefore, Remed Co's FCF Margin % for the quarter that ended in Mar. 2025 was 15.34%.

As of today, Remed Co's current FCF Yield % is 1.51%.

The historical rank and industry rank for Remed Co's FCF Margin % or its related term are showing as below:

XKRX:302550' s FCF Margin % Range Over the Past 10 Years
Min: -66.52 Med: -5.25 Max: 14.05
Current: 5.82

During the past 8 years, the highest FCF Margin % of Remed Co was 14.05%. The lowest was -66.52%. And the median was -5.25%.

XKRX:302550's FCF Margin % is ranked better than
67.11% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: -2.57 vs XKRX:302550: 5.82

Remed Co FCF Margin % Historical Data

The historical data trend for Remed Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co FCF Margin % Chart

Remed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-37.68

-40.68

0.76

14.05

2.49

Remed Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Margin %	Get a 7-Day Free Trial															1.34	20.32	55.05	-67.22	15.34

Competitive Comparison of Remed Co's FCF Margin %

For the Medical Devices subindustry, Remed Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Remed Co's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remed Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Remed Co's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Remed Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Remed Co's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	635.724	/	25554.051
	=	2.49 %

Remed Co's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	988.623	/	6443.49
	=	15.34 %

Remed Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Remed Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Remed Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025

Website

http://www.remed.kr

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co Headlines

No Headlines